• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见口腔状况综述。

Common Oral Conditions: A Review.

机构信息

Penn Dental Medicine, Philadelphia, Pennsylvania.

Miami Cancer Institute, Baptist Health South Florida, Herbert Wertheim College of Medicine, Florida International University, Miami.

出版信息

JAMA. 2024 Mar 26;331(12):1045-1054. doi: 10.1001/jama.2024.0953.

DOI:10.1001/jama.2024.0953
PMID:38530258
Abstract

IMPORTANCE

Dry mouth, oral candidiasis, and recurrent aphthous ulcers are 3 of the most common oral conditions that may be associated with patient discomfort, decreased quality of life, and morbidity.

OBSERVATIONS

In a meta-analysis of 26 population-based cohort and cross-sectional studies, the global prevalence of dry mouth symptoms was 23% (95% CI, 18% to 28%), placing individuals at risk of oral candidiasis, dental caries, dysgeusia, masticatory/speech impairment, and oropharyngeal dysphagia. Dry mouth is associated with using more than 3 oral medications per day (odds ratio [OR], 2.9 [95% CI, 1.4 to 6.2]), head and neck radiation, and Sjögren disease. Symptoms may include difficulty swallowing and speaking, thirst, and halitosis. Dry mouth is associated with an 11.5% (95% CI, 3.6% to 27%) higher risk of oral candidiasis, based on a meta-analysis of 6 observational cohorts. Management of dry mouth includes mechanical salivary stimulants, oral moisturizers, and/or systemic sialagogues. Oral candidiasis is an opportunistic fungal infection caused by overgrowth of the Candida genus with C albicans, which accounts for 76.8% of infections. The prevalence of oral candidiasis is higher in patients who are immunosuppressed, for example, those with HIV (35% [95% CI, 28% to 42%]) and those with salivary gland hypofunction (OR, 3.02 [95% CI, 1.73 to 5.28]). Common risk factors associated with oral candidiasis include use of antibiotics (P = .04) and oral mucosal disorders such as lichen planus. Oral burning and dysgeusia are common symptoms of oral candidiasis. Treatment includes addressing risk factors and use of topical and/or systemic antifungal medications. Recurrent aphthous stomatitis is characterized by symptomatic round or oval oral ulcers, which are covered by a gray-white fibrin layer and encircled by an erythematous ring. A meta-analysis of 10 case-controlled studies revealed an increased risk of recurrent aphthous stomatitis associated with polymorphism of IL-1β (+3954C/T) (OR, 1.52 [95% CI, 1.07 to 2.17]) and IL-1β (-511C/T) (OR, 1.35 [95% CI, 1.09 to 1.67]). Another meta-analysis of 9 case-control studies reported that patients with recurrent aphthous stomatitis had a higher frequency of nutritional deficiencies, including vitamin B12 (OR, 3.75 [95% CI, 2.38 to 5.94]), folic acid (OR, 7.55 [95% CI, 3.91 to 14.60]), and ferritin (OR, 2.62 [95% CI, 1.69 to 4.06]). Recurrent aphthous stomatitis can be associated with systemic diseases. A meta-analysis of 21 case-control studies revealed that celiac disease is associated with a higher incidence of recurrent aphthous stomatitis (25% vs 11%; OR, 3.79 [95% CI, 2.67 to 5.39]; P <.001). Topical corticosteroids are first-line agents to manage recurrent aphthous stomatitis; however, systemic medications may be necessary in more severe cases.

CONCLUSIONS AND RELEVANCE

Dry mouth, oral candidiasis, and recurrent aphthous ulcers are common oral conditions that may be associated with patient discomfort, decreased quality of life, and morbidity. First-line treatment includes over-the-counter sialagogues for dry mouth, topical antifungals for oral candidiasis, and topical corticosteroids for aphthous ulcers. Oral conditions that do not improve with first-line treatment may require treatment with systemic medications.

摘要

重要性

口干、口腔念珠菌病和复发性阿弗他溃疡是三种最常见的口腔疾病,可能与患者不适、生活质量下降和发病率有关。

观察结果

在对 26 项基于人群的队列研究和横断面研究的荟萃分析中,口干症状的全球患病率为 23%(95%CI,18%至 28%),使个体面临口腔念珠菌病、龋齿、味觉障碍、咀嚼/言语障碍和口咽吞咽困难的风险。口干与每天使用超过 3 种口腔药物(比值比[OR],2.9[95%CI,1.4 至 6.2])、头颈部放疗和干燥综合征有关。症状可能包括吞咽和说话困难、口渴和口臭。基于对 6 项观察性队列的荟萃分析,口干与口腔念珠菌病的风险增加 11.5%(95%CI,3.6%至 27%)相关。口干的管理包括机械唾液刺激剂、口腔保湿剂和/或全身唾液分泌剂。口腔念珠菌病是一种机会性真菌感染,由念珠菌属过度生长引起,其中白色念珠菌占 76.8%的感染。免疫抑制患者(例如 HIV 患者[35%(95%CI,28%至 42%])和唾液腺功能低下患者(OR,3.02[95%CI,1.73 至 5.28])的口腔念珠菌病患病率较高。与口腔念珠菌病相关的常见危险因素包括使用抗生素(P=.04)和口腔黏膜疾病,如扁平苔藓。口腔烧灼感和味觉障碍是口腔念珠菌病的常见症状。治疗包括解决危险因素和使用局部和/或全身抗真菌药物。复发性阿弗他口腔溃疡的特征是有症状的圆形或椭圆形口腔溃疡,溃疡表面覆盖着灰白色纤维蛋白层,周围环绕着红斑环。对 10 项病例对照研究的荟萃分析显示,白细胞介素-1β(+3954C/T)(OR,1.52[95%CI,1.07 至 2.17])和白细胞介素-1β(-511C/T)(OR,1.35[95%CI,1.09 至 1.67])多态性与复发性阿弗他口腔溃疡的风险增加相关。对 9 项病例对照研究的另一项荟萃分析报告称,复发性阿弗他口腔溃疡患者更频繁地出现营养缺乏,包括维生素 B12(OR,3.75[95%CI,2.38 至 5.94])、叶酸(OR,7.55[95%CI,3.91 至 14.60])和铁蛋白(OR,2.62[95%CI,1.69 至 4.06])。复发性阿弗他口腔溃疡可能与系统性疾病有关。对 21 项病例对照研究的荟萃分析显示,乳糜泻与复发性阿弗他口腔溃疡的发生率较高(25%比 11%;OR,3.79[95%CI,2.67 至 5.39];P<.001)有关。局部皮质类固醇是治疗复发性阿弗他口腔溃疡的一线药物;然而,在更严重的情况下,可能需要使用全身药物。

结论和相关性

口干、口腔念珠菌病和复发性阿弗他溃疡是常见的口腔疾病,可能与患者不适、生活质量下降和发病率有关。一线治疗包括口干的非处方唾液分泌剂、口腔念珠菌病的局部抗真菌药物和阿弗他溃疡的局部皮质类固醇。一线治疗无效的口腔疾病可能需要使用全身药物治疗。

相似文献

1
Common Oral Conditions: A Review.常见口腔状况综述。
JAMA. 2024 Mar 26;331(12):1045-1054. doi: 10.1001/jama.2024.0953.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Interventions for the management of oral ulcers in Behçet's disease.白塞病口腔溃疡的管理干预措施。
Cochrane Database Syst Rev. 2014 Sep 25;2014(9):CD011018. doi: 10.1002/14651858.CD011018.pub2.
4
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
5
Topical antiseptics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗菌剂。
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013055. doi: 10.1002/14651858.CD013055.pub3.
6
Interventions for the management of dry mouth: non-pharmacological interventions.口干管理的干预措施:非药物干预措施
Cochrane Database Syst Rev. 2013 Aug 30(8):CD009603. doi: 10.1002/14651858.CD009603.pub2.
7
Sexual Harassment and Prevention Training性骚扰与预防培训
8
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.成人及儿童中与HIV感染相关的口腔念珠菌病的预防及管理干预措施。
Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003940. doi: 10.1002/14651858.CD003940.pub3.
9
Interventions for the management of dry mouth: non-pharmacological interventions.口干管理的干预措施:非药物干预
Cochrane Database Syst Rev. 2013 Sep 5;2013(9):CD009603. doi: 10.1002/14651858.CD009603.pub3.
10
Interventions for the management of dry mouth: topical therapies.口干管理的干预措施:局部治疗
Cochrane Database Syst Rev. 2011 Dec 7(12):CD008934. doi: 10.1002/14651858.CD008934.pub2.

引用本文的文献

1
The next generation of dental treatments: Leveraging smart-responsive nanomaterials for unique oral environments.下一代牙科治疗:利用智能响应纳米材料应对独特的口腔环境。
Mater Today Bio. 2025 Jul 5;33:102057. doi: 10.1016/j.mtbio.2025.102057. eCollection 2025 Aug.
2
Development of an Antimicrobial Coating Film for Denture Lining Materials.用于义齿衬里材料的抗菌涂层薄膜的研制
Pharmaceutics. 2025 Jul 11;17(7):902. doi: 10.3390/pharmaceutics17070902.
3
Errors in Data Reported in Review.综述中报告的数据错误。
JAMA. 2025 Aug 12;334(6):545. doi: 10.1001/jama.2025.12709.
4
Comparison of herbal products with antifungal drugs in cure of oral candidiasis: A systematic review.草药产品与抗真菌药物治疗口腔念珠菌病的比较:一项系统评价。
Dent Res J (Isfahan). 2025 Jun 27;22:23. doi: 10.4103/drj.drj_415_24. eCollection 2025.
5
Application of machine learning for the analysis of peripheral blood biomarkers in oral mucosal diseases: a cross-sectional study.机器学习在口腔黏膜疾病外周血生物标志物分析中的应用:一项横断面研究。
BMC Oral Health. 2025 May 10;25(1):703. doi: 10.1186/s12903-025-06095-y.
6
Internal-External Homologous Drug-Loaded Exosome-Like Nanovesicles Released from Semi-IPN Hydrogel Enhancing Wound Healing of Chemoradiotherapy-Induced Oral Mucositis.从半互穿网络水凝胶释放的内外同源载药类外泌体纳米囊泡促进放化疗引起的口腔黏膜炎伤口愈合
Int J Nanomedicine. 2025 Apr 4;20:4105-4121. doi: 10.2147/IJN.S508530. eCollection 2025.
7
The symptom network of oral health conditions in older populations with oral frailty: a cross-sectional study.口腔功能衰退的老年人群口腔健康状况的症状网络:一项横断面研究。
BMC Oral Health. 2025 Apr 1;25(1):471. doi: 10.1186/s12903-025-05795-9.
8
The Oral Microbial Ecosystem in Age-Related Xerostomia: A Critical Review.与年龄相关的口干症中的口腔微生物生态系统:一项批判性综述。
Int J Mol Sci. 2024 Nov 28;25(23):12815. doi: 10.3390/ijms252312815.
9
Uncovering Molecular and Genetic Drivers of Dental Caries Via scRNA-seq and Mendelian Randomisation.通过单细胞RNA测序和孟德尔随机化揭示龋齿的分子和遗传驱动因素
Int Dent J. 2025 Apr;75(2):668-682. doi: 10.1016/j.identj.2024.10.005. Epub 2024 Nov 7.
10
Disproportionality analysis of drug-induced dry mouth using data from the United States food and drug administration adverse event reporting system database.利用美国食品药品监督管理局不良事件报告系统数据库中的数据对药物性口干进行不成比例分析。
Heliyon. 2024 Sep 26;10(19):e38561. doi: 10.1016/j.heliyon.2024.e38561. eCollection 2024 Oct 15.